HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.

AbstractPURPOSE:
Growth factors, particularly insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR) in some nonendocrine and a few endocrine tumors, are thought important in recurrence, growth, and aggressiveness. Whether this is true of neuroendocrine tumors such as gastrinomas is unclear. The aim of this study was to address this question in gastrinomas.
EXPERIMENTAL DESIGN:
IGF-I and IGF-IR expression in gastrinomas from 54 patients with Zollinger-Ellison syndrome were analyzed and correlated with clinical/tumor characteristics. IGF-I and IGF-IR mRNA levels were determined by competitive reverse transcription-PCR. IGF-IR expression, assessed by immunohistochemistry, was done on a subset.
RESULTS:
IGF-IR mRNA was found in 100% and IGF-I in 89%. IGF-I mRNA expression varied by >254-fold, IGF-IR by 2,670-fold, and the levels correlated in a given tumor. The IGF-IR level was lower in gastrinomas of patients who were rendered disease free and increased levels correlated with tumor growth, aggressiveness, extent, and with liver metastases. Increased IGF-I levels correlated with increased growth, tumor extent, and aggressiveness. Neither IGF-IR nor IGF-I levels correlated with tumor location, size, or its clinical/functional features. The IGF-IR correlated with disease-free survival. IGF-IRbeta was found in 31 of 32 tumors (97%) by immunohistochemistry.
CONCLUSIONS:
These results indicate that IGF-I and IGF-IR are expressed in almost all gastrinomas. Furthermore, assessment of IGF-I/IGF-IR expression in gastrinomas may be clinically useful in identifying those patients with more aggressive tumors who might benefit from more aggressive treatment.
AuthorsMasayuki Furukawa, Mark Raffeld, Carmen Mateo, Akio Sakamoto, Terry W Moody, Tetsuhide Ito, David J Venzon, Jose Serrano, Robert T Jensen
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 11 Issue 9 Pg. 3233-42 (May 01 2005) ISSN: 1078-0432 [Print] United States
PMID15867218 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • RNA, Messenger
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1
Topics
  • Adolescent
  • Adult
  • Aged
  • Cell Proliferation
  • Disease-Free Survival
  • Female
  • Gastrinoma (genetics, metabolism, pathology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Insulin-Like Growth Factor I (genetics, metabolism)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • RNA, Messenger (genetics, metabolism)
  • Receptor, IGF Type 1 (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: